CBER Reviewers To Remain Accessible Post-Merger, CDER Tells BLA Sponsors
Executive Summary
CBER product reviewers will remain accessible to biologics sponsors following the consolidation of the agency's drug and biologics centers, CDER Deputy Director Steven Galson said